Bone Metastasis Treatment Market Share Size will Observe Lucrative Surge by the End 2027

Bone Metastasis Treatment Market: Introduction

Bone metastasis is a type of cancer that occurs when cancer cells from other parts of the body affect the bone. Bone metastasis is also called metastatic bone disease or secondary bone cancer.
Almost all types of cancers can spread to the bone. However, particular types of cancer such as breast cancer and prostate cancer spread rapidly to the bone.
Bone metastasis occurs to the people who were diagnosed with cancer early in their life. Also, the patients with advanced stage cancer are more prone to develop bone metastasis.
The bone metastasis can occur to any bone, but it commonly affects the bones in thighs, pelvis, and spine.
Bone metastasis is of two different types – osteoblastic bone metastasis which occurs due to metastasized prostate cancer and osteolytic bone metastasis caused due to metastasized breast cancer
Common symptoms of bone metastasis are bone pain, broken bone, urinary and bowel incontinence, weakness in the legs and arms, and high levels of calcium in the blood
The treatment of bone metastasis is aimed at providing the patient a quality and longer life

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Report

Global Bone Metastasis Treatment Market: Key Drivers

The global bone metastasis treatment market is primarily driven by high prevalence and rise in incidence rates of underlying causes of bone metastasis such as breast cancer and prostate cancer
According to the World Health Organization (WHO), every year, more than 2.1 million women are diagnosed with breast cancer. In 2018, around 627,000 women died due to breast cancer across the globe.
According to Globocan, globally around 1,276,106 new cases of prostate cancer were reported in 2018. Thus, high prevalence and rise in incidence rates of bone metastasis across the globe is one the key factors estimated to drive the bone metastasis treatment market during the forecast period.
Also, technological advancements in early diagnosis of bone metastasis, new product development, and strong clinical trial pipeline products for the treatment of bone metastasis are likely to boost the growth of the market

Osteoblastic Bone Metastasis Segment to Dominate Global Market

In terms of cancer type, the global bone metastasis treatment market can be segmented into osteoblastic bone metastasis and osteolytic bone metastasis. The osteoblastic bone metastasis segment is projected to dominate the global market during the forecast period.
The osteoblastic bone metastasis is caused due to underlying breast cancer in women. High prevalence of breast cancer compared to other types of cancers is estimated to contribute to the dominant share of the segment during the forecast period.

Chemotherapy Segment to Offer Attractive Opportunity

In terms of therapy, the global bone metastasis treatment market is segmented into chemotherapy, hormone therapy, targeted therapy, immunotherapy, radiopharmaceuticals, and others. The others segment comprises bisphosphonate drugs and denosumab drugs.

Looking for Regional Analysis or Competitive Landscape, Ask for a Customized Report